Results 201 to 210 of about 4,927,702 (244)

Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan

European Journal of Clinical Microbiology & Infectious Diseases, 2010
In Taiwan, the 23-valent pneumococcal polysaccharide vaccine (PPV23) and the 7-valent pneumococcal conjugate vaccine (PCV7) have been available since January 2001 and October 2005, respectively. A hospital-based surveillance of invasive pneumococcal disease (IPD) in a medical center was conducted from 2000 to 2008 to evaluate the epidemiologic changes ...
W-H, Liao, S-H, Lin, C-C, Lai, C-K, Tan, C-H, Liao, Y-T, Huang, C-Y, Wang, P-R, Hsueh   +7 more
openaire   +2 more sources

Pneumococcal disease

Practice Nursing, 2008
Jeannett Martin reviews the risks of pneumococcal disease and the indications for vaccination
openaire   +1 more source

Prevention and management of pneumococcal disease

Nursing Standard, 2001
Pneumococcal pneumonia is associated with high mortality in immunocompromised and older people. The authors discuss the role nurses have in increasing awareness of vaccination and use of preventive interventions to target at-risk patients.
L, King, J, Burns
openaire   +2 more sources

The future of pneumococcal disease prevention

Vaccine, 2011
Pneumococcal disease (PD) is the leading cause of vaccine preventable deaths in children
Gail L, Rodgers, Keith P, Klugman
openaire   +2 more sources

Invasive Pneumococcal and Meningococcal Disease

Infectious Disease Clinics of North America, 2019
This review focuses on current knowledge of the epidemiology, prevention, and treatment of invasive pneumococcal (IPD) and meningococcal disease (IMD). IPD decreased significantly with the introduction of effective conjugate vaccines but is on the rise again.
Deirdre, Fitzgerald, Grant W, Waterer
openaire   +2 more sources

Influenza and pneumococcal disease in the community

Nursing Standard, 2003
The authors discuss the aetiology, diagnosis and prevention of influenza and pneumococcal disease, identifying who should be vaccinated and those who are at risk. Useful information on how to plan an immunisation campaign is also outlined.
Cate, Riley, Steven, Riley
openaire   +2 more sources

The Prevention of Pneumococcal Disease in Children

New England Journal of Medicine, 2001
Streptococcus pneumoniae accounts for half of all cases of acute otitis media, and it remains a major cause of illness and death in children. The strategies for prevention now include the use of a conjugate vaccine to induce immunity in infants, who are the group at highest risk.
openaire   +2 more sources

An Epidemiologic Approach to Pneumococcal Disease

Clinical Infectious Diseases, 1981
In many countries of the developing world, pneumonia remains a leading cause of morbidity and premature mortality. In their quest for effective control measures not dependent on the socioeconomic changes in Western societies that have paralleled a reduction in mortality from pneumonia, these poorer countries are looking towards modern antibiotic ...
I D, Riley, R M, Douglas
openaire   +2 more sources

Smoking and Pneumococcal Disease

New England Journal of Medicine, 2000
C A, Fleming, D E, Craven
openaire   +2 more sources

Strategies for the control of pneumococcal diseases

Vaccine, 1999
Streptococcus pneumoniae (pneumococcus) is a Gram-positive, encapsulated bacteria that is a major cause of human disease in people of all ages. It is the most important cause of bacterial pneumonia in infancy, childhood and adult life, and the most important cause of meningitis in all age groups except children of 3 months to 2 years in whom ...
openaire   +2 more sources